MC
AGN

Moors & Cabot’s Allergan Inc AGN Stock Holding History

Moors & Cabot’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-2,554
Closed -$543K – 552
2014
Q4 		$543K Sell
2,554
-91
-3% -$18.1K 0.09% 249
2014
Q3 		$470K Sell
2,645
-34
-1% -$5.65K 0.08% 267
2014
Q2 		$453K Buy
2,679
+30
+1% +$4.67K 0.08% 285
2014
Q1 		$329K Buy
+2,649
New +$323K 0.08% 255

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Moors & Cabot's AGN Position: Q1 2015 in Review

Moors & Cabot sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 2,554 shares — an estimated $543K sold.

Moors & Cabot first reported a position in AGN in Q1 2014 and held it in 4 quarters. The position peaked at $543K in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Moors & Cabot reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Moors & Cabot sold 2,554 Allergan Inc shares in Q1 2015, an estimated $543K.
  • Moors & Cabot first reported a position in Allergan Inc in Q1 2014 and held it in 4 quarters.
  • Moors & Cabot's Allergan Inc position peaked at $543K in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Moors & Cabot's 13F filing for Q1 2015, filed 14 May 2015.